Preventing dataset shift from breaking machine-learning biomarkers
Machine learning brings the hope of finding new biomarkers extracted from cohorts with rich biomedical measurements. A good biomarker is one that gives reliable detection of the corresponding condition. However, biomarkers are often extracted from a cohort that differs from the target population. Such a mismatch, known as a dataset shift, can undermine the application of the biomarker to new individuals. Dataset shifts are frequent in biomedical research, e.g. because of recruitment biases. When a dataset shift occurs, standard machine-learning techniques do not suffice to extract and validate biomarkers. This article provides an overview of when and how dataset shifts breaks machine-learning extracted biomarkers, as well as detection and correction strategies.
Code (1)
Tasks
BIG-bench Machine LearningSimilar Papers 제목 키워드 기반
Integration of Radiomics and Tumor Biomarkers in Interpretable Machine Learning Models
Despite the unprecedented performance of deep neural networks (DNNs) in computer vision, their practical application in the diagnosis and prognosis of cancer using medical imaging has been limited. One of the critical ch…
Diagnosticfeature selectionInterpretable Machine LearningPrognosisBinary disease prediction using tail quantiles of the distribution of continuous biomarkers
In the analysis of binary disease classification, single biomarkers might not have significant discriminating power and multiple biomarkers from a large set of biomarkers should be selected. Numerous approaches exist, bu…
Binary ClassificationClassificationDisease PredictionGeneral ClassificationDefending Against Alignment-Breaking Attacks via Robustly Aligned LLM
Recently, Large Language Models (LLMs) have made significant advancements and are now widely used across various domains. Unfortunately, there has been a rising concern that LLMs can be misused to generate harmful or mal…
Resting-state functional connectivity-based biomarkers and functional MRI-based neurofeedback for psychiatric disorders: a challenge for developing theranostic biomarkers
Psychiatric research has been hampered by an explanatory gap between psychiatric symptoms and their neural underpinnings, which has resulted in poor treatment outcomes. This situation has prompted us to shift from sympto…
Functional ConnectivityIdentification of Prognostic Biomarkers for Stage III Non-Small Cell Lung Carcinoma in Female Nonsmokers Using Machine Learning
Lung cancer remains a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) being the most common subtype. This study aimed to identify key biomarkers associated with stage III NSCLC in…